Dermal filler offers confidence for cleft lip patients, but experts warn of industry exploitation risks
Two young women who underwent cleft lip surgery as children are now using dermal fillers to restore their facial symmetry and reclaim their sense of self, but medical professionals are sounding the alarm over a rapidly expanding aesthetic industry that operates with little oversight. Amber Dorgan, 20, from Neath, and Emily Evans, 21, from Kidwelly, have both turned to injectable treatments after years of living with the visible scars remaining from their congenital condition, yet the same practitioners are also warning that vulnerable patients are being deliberately targeted by the unregulated aesthetic sector.
The treatment that is changing lives
Amber Dorgan recounts a childhood spent feeling different, navigating school corridors with her visible scarring and the accompanying anxiety that came with every social interaction. Born with a cleft lip that required five successive operations during childhood, she endured not only the physical reconstruction but also the psychological toll of bullying and constant self-consciousness. Today, she relies on free dermal filler injections at the Welsh Centre for Cleft Lip and Palate in Morriston Hospital, a service that has become her lifelong care pathway after surgery.
“I’ve always been insecure about how I look, going out and about,” Dorgan explains. “I’ve always had anxiety and I just get nervous.” The filler treatment, which she received after researching options through social media and working with local practitioners, has transformed her emotional landscape. Before the procedure, she describes herself as “really shy,” someone who would avoid conversation and feared leaving the house. Now, the appearance changes she once feared have been smoothed away, and she finds herself more willing to engage with others and navigate social situations with greater confidence.
Emily Evans, another survivor of the condition, shares a similar narrative of isolation and self-doubt. Born with a cleft lip that necessitated two surgical interventions—one as an infant and another at age ten—Evans spent much of her formative years feeling like an outsider. “Nobody hates anything more than being different,” she reflects, describing a childhood marked by peers asking questions about her appearance and a persistent feeling of alienation. At seventeen, when she was finally discharged from cleft services, she was never offered filler treatment despite her desire for it, and was instead directed to maintain regular contact with her care team. The decision to seek aesthetic intervention came later, after she discovered practitioners in England offering dermal fillers specifically for scarring from cleft lip surgery.
Evans, now a stay-at-home mother of two young children, has taken the step to have her lips filled at a clinic run by Summer Rose-Dorland, a Somerset-based practitioner who has expanded her reach through pop-up clinics in Wales. The treatment has given her the confidence she spent years seeking, though she acknowledges that the decision to pursue such a significant cosmetic alteration is deeply personal and not without its questions.
A call for regulation in an unregulated industry
While the women’s experiences highlight the potential benefits of dermal fillers for those with cleft lip and palate scars, the broader landscape of aesthetic treatment for these conditions is marred by a significant absence of oversight. The UK aesthetic industry, which is currently unregulated, has seen a surge in practitioners offering filler treatments specifically designed to address the visible differences that many cleft lip patients carry into adulthood. For those without access to NHS services—which covers lifelong care for cleft conditions—private clinics are becoming an increasingly popular alternative.
Summer Rose-Dorland, who qualified four years ago and has since completed twenty training courses, works alongside the non-profit organisation CleftInject, which connects adults with scarring from cleft lip surgery to practitioners who understand the unique challenges of their condition. The charity has been instrumental in expanding access, offering free dermal filler treatments for many patients, particularly for those seeking their first procedure. “A lot of my clients struggle with their scar,” Rose-Dorland explains. “They have messages from people that say they had to stand sideways in photos or adjust how they talk just to make others comfortable with what they see.”
The conversation around regulation has been particularly urgent following research by Dr Nicola Stock, an associate professor at the University of the West of England’s Centre for Appearance Research. Her work has examined the psychological impact of appearance-altering conditions such as cleft lip, and it has revealed a troubling trend: despite receiving surgical correction of the deformity, many adults born with a cleft lip and palate continue to harbour concerns about their appearance. The research also indicates a marked increase in interest among this group for aesthetic treatments like dermal fillers.
Stock suggests that the current marketing of these procedures on social media is fueling the demand, with the aesthetic industry playing a predominant role in shaping public perception. “Within the general population, dermal filler has exploded in popularity in recent years, and it’s now one of the most common non-surgical cosmetic procedures used worldwide,” she states. “And we believe that this is being fuelled predominately by the aesthetics industry and, predominantly, on social media.”
The psychological impact and exploitation concerns
The intersection of medical vulnerability and cosmetic desire has raised serious questions about the exploitation of patients with cleft lip. Dr Neil Brierley, a consultant cleft and plastic surgeon with the West Midlands Cleft Service, emphasises the importance of directing individuals with such conditions toward NHS teams when possible. “What we don’t want is to have people who are potentially vulnerable who are looking for a quick fix or a solution to feel they don’t have an option to come back to the NHS,” Dr Brierley says. “And they certainly do not have to, but we are here if they need us.”
The surgeon stresses that the NHS provides an unbiased perspective, offering appropriate care without the pressure or profit motives that can accompany private aesthetic clinics. However, with the current lack of regulations governing injectable treatments across the UK, the risk of sub-standard practices looms large. “There will be many excellent practitioners out there, but it will be impossible to know in advance if there is someone who isn’t following best practice,” Dr Brierley notes. He advocates for greater awareness among patients about the importance of informing their cleft care teams before any cosmetic procedure, particularly because filler placement can complicate future surgical interventions.
Dr Stock echoes these concerns, pointing to the growing research around how dermal fillers are being marketed to cleft lip patients. “I’ve been worried that adults with a cleft lip, who have a complex medical history, are being deliberately targeted and left vulnerable to potential harm and exploitation at the hands of the aesthetics industry,” she says. “Until there are more guidelines in the sector, I recommend that anyone considering dermal filler should research their options and get in touch with their local NHS cleft team or contact the Cleft Lip and Palate Action charity.”
The situation is further complicated by the fact that some practitioners working with the CleftInject network offer treatments for free, which may create an incentive structure that prioritizes volume over quality. While these discounts are intended to improve access, they also underscore the financial vulnerability of patients who may otherwise be unable to afford aesthetic care. For Amber Dorgan, the NHS-provided filler is not only an emotional lifeline but also a symbol of a system that, despite its imperfections, remains dedicated to the long-term well-being of those with cleft lip and palate.
Why it Matters
The story of Dorgan and Evans illuminates a broader crisis in healthcare delivery: when medical conditions that require lifelong support become entangled with the commercial incentives of an unregulated aesthetic industry, the result is not just a risk to patient safety but a deepening of psychological distress. For thousands of individuals living with cleft lip and palate, the visible scarring that results from congenital surgery is often more than a cosmetic concern—it is a source of lifelong self-consciousness that can shape social interactions, educational experiences, and personal identity. When the industry that offers potential relief operates without accountability, the consequences can be severe, from worsening mental health to complications with future surgical plans.
The exploitation risk is particularly acute because patients with cleft lip already navigate a complex medical landscape. Their conditions affect feeding, hearing, dental development, and speech, and they frequently encounter stigma and bullying. Adding the pressure of cosmetic enhancement to this difficult journey creates a vulnerable population that is susceptible to predatory marketing and unsupervised treatment. The current state of regulation, which allows non-medics to provide these injections without oversight, leaves little room for ensuring that procedures are performed safely and ethically.
However, this challenge also presents an opportunity. The same research identifying a demand for filler treatments highlights the need for better public education about the NHS options that are available. Dr Stock’s work underscores that many adults with cleft lip still seek enhancement, and this desire should not outweigh the access to evidence-based, medically supervised care. By demanding regulation that protects patients while still making quality treatment accessible, the healthcare community can honour both the dignity of those with cleft lip and the legitimate desire for the confidence that a simple, well-placed filler can bring.
The future of this issue hinges on balancing compassion with caution. Patients deserve the dignity of being seen as whole people rather than as cases for aesthetic correction. At the same time, the industry must be held to standards that prevent exploitation and ensure that every treatment decision is made with full awareness of its potential risks. Until then, the stories of Dorgan, Evans, and their care teams serve as a powerful reminder of why these issues cannot be ignored.
